Article Versions Notes

Borella F, Fucina S, Seminara Y, Denti P, Ferraioli D, Bertero L, Gallio N, Cusato J, Valabrega G, Revelli A, et al. Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications. Current Oncology. 2024; 31(12):8054-8074. https://doi.org/10.3390/curroncol31120594

Borella, Fulvio, Stefano Fucina, Ylenia Seminara, Pietro Denti, Domenico Ferraioli, Luca Bertero, Niccolò Gallio, Jessica Cusato, Giorgio Valabrega, Alberto Revelli, and et al. 2024. "Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications" Current Oncology 31, no. 12: 8054-8074. https://doi.org/10.3390/curroncol31120594

Borella, F., Fucina, S., Seminara, Y., Denti, P., Ferraioli, D., Bertero, L., Gallio, N., Cusato, J., Valabrega, G., Revelli, A., Marozio, L., & Cosma, S. (2024). Targeting TOP2A in Ovarian Cancer: Biological and Clinical Implications. Current Oncology, 31(12), 8054-8074. https://doi.org/10.3390/curroncol31120594